for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
PharmAsia News
   Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1875-7774
     Published by Informa plc Homepage  [13 journals]
  • Data Integrity Concerns Halt IPCA’s U.S. Exports
    • Abstract: Mumbai-based IPCA Laboratories is the latest casualty in a long series of data integrity issues that have crippled Indian drug companies. IPCA said it received observations from the U.S.
      PubDate: Fri, 25 Jul 2014 10:00:01 -040
       
  • Lundbeck To Challenge India Ban on Deanxit Antidepressant
    • Abstract: Lundbeck is to launch a court challenge to back-and-forth decisions by India's health ministry that ended up banning its Deanxit (flupentixol/melitracen) antidepressant because it had not been approved in developed countries.
      PubDate: Fri, 25 Jul 2014 03:10:03 -040
       
  • China To Set Up Dedicated Intellectual Property Courts
    • Abstract: China's government, faced with 90,000 legal cases involving intellectual property, seven times the number eight years ago, has decided to establish courts dedicated to the field, probably in the largest cities.
      PubDate: Fri, 25 Jul 2014 03:00:00 -040
       
  • Hikma To Buy Large U.S. Ben Venue R&D Complex
    • Abstract: Hikma Pharmaceuticals is planning to buy a large U.S. Ben Venue Laboratories manufacturing and research and development complex in a Cleveland suburb.
      PubDate: Fri, 25 Jul 2014 02:55:01 -040
       
  • Center For Drug Evaluation To Speed Up Generic Reviews
    • Abstract: The head of the Center for Drug Evaluation (CDE) has stated that the body is aiming to speed up the review process for selected generic drugs this year, especially for those products in great clinical need.
      PubDate: Fri, 25 Jul 2014 02:40:00 -040
       
  • Beijing HFPC To Promote Reasonable Medical Costs
    • Abstract: The director of the Beijing Municipal Health and Family Planning Commission (HFPC) has stated that the city will continue to promote reasonable prices for medical services and a decline in drug prices.
      PubDate: Fri, 25 Jul 2014 02:35:00 -040
       
  • WeChat Intends To Enter Wearable Medical Device Market
    • Abstract: One of China’s internet giants, Ma Huateng, chairman of portal Tencent, has said he intends to enter the wearable medical device industry by utilizing the popular social media application, WeChat, to collect health information from users.
      PubDate: Fri, 25 Jul 2014 02:05:00 -040
       
  • Cuba’s Largest State-owned Pharma Company Visits Guangdong
    • Abstract: Before President Xi Jinping’s recent visit to Latin America, during which China and Cuba signed a number of cooperation contracts in the biotechnology field, Cuba’s largest state-owned pharmaceutical company visited Guangdong several times seeking potential cooperation in the biopharmaceutical sector.
      PubDate: Fri, 25 Jul 2014 01:50:02 -040
       
  • Dispute Over ‘Unconventional’ Approval Of Gene Sequencing
           Product
    • Abstract: The associate director of the Beijing Institute of Genomic DNA Sequencing Technology R&D Center under the Chinese Academy Of Science published an article on July 15 questioning whether it was legal for the China FDA to accelerate the review and approval for a second-generation gene sequencer from Beijing Genomics Institute (BGI).
      PubDate: Fri, 25 Jul 2014 01:45:01 -040
       
  • Emerging Markets Earnings Roundup: GlaxoSmithKline (Part 4)
    • Abstract: GlaxoSmithKline CEO Andrew Witty took a question on the China compliance investigation and quickly moved on in an earnings call also thin on emerging market plans. However, the earnings release added a bit of detail on both fronts, including up-to-date details on regulatory aspects outside of China.
      PubDate: Thu, 24 Jul 2014 21:50:02 -040
       
  • Ranbaxy, Cipher Agree To Expand Acne Drug License To Brazil
    • Abstract: Ranbaxy Laboratories and Cipher Pharmaceuticals have signed an agreement extending their distribution and marketing contract for the Canada drug maker's Absorica (isotretinoin) acne treatment in Brazil.
      PubDate: Thu, 24 Jul 2014 18:40:06 -040
       
  • Ipca Halts Exports To U.S. From FDA-Cited Production Plant In India
    • Abstract: The U.S. FDA has flagged another India production plant for violations, this time an Ipca Laboratories facility in central India, leaving the company only two U.S.
      PubDate: Thu, 24 Jul 2014 18:40:01 -040
       
  • Ono, BMS Agree To Joint Development, Marketing Of Cancer Drugs
    • Abstract: Ono Pharmaceutical and Bristol-Myers Squibb have agreed to 50-50 joint development and marketing several immunotherapies of the Japan-based company.
      PubDate: Thu, 24 Jul 2014 18:35:01 -040
       
  • BMS Promotes Tyagi To India Country Head
    • Abstract: Jitendra Tyagi, a four-year veteran at Bristol-Myers Squibb India, has been named head of the subsidiary, reporting to the U.S.-based company's general manager for the Middle East, Africa and India.
      PubDate: Thu, 24 Jul 2014 02:55:08 -040
       
  • Hyderabad Proposes ‘Pharma City’ To Attract Firms
    • Abstract: A “pharma city” within an existing big city is being proposed in India's Hyderabad by its chief minister, who said the plan would include residential housing for company employees and a dedicated power plant.
      PubDate: Thu, 24 Jul 2014 02:55:05 -040
       
  • Japan To Offer Brazil Expertise To Speed Drug Approvals
    • Abstract: Japan has drafted plans to provide expertise to Brazil that would enable the South American nation to speed its ability to test the safety of new drugs.
      PubDate: Thu, 24 Jul 2014 02:55:02 -040
       
  • Japan Elderly Care Homes Hit By Visit Payment Cuts
    • Abstract: At least 155 nursing homes and facilities for the elderly around Japan have been badly affected by the cut in remuneration paid to medical institutions for providing such facilities with visiting doctor consultations, a recent nationwide survey suggests.
      PubDate: Thu, 24 Jul 2014 00:15:01 -040
       
  • NEDO Sees Robots Helping Care For Japan’s Aging Society
    • Abstract: NEDO Japan is proposing the use of robot technology to help solve social problems such as the aging population and the provision of nursing care.
      PubDate: Thu, 24 Jul 2014 00:10:01 -040
       
  • PMDA: Regulatory Strategy Consultations Exceed 200 In First Half
    • Abstract: A total of 684 individual consultations, which involved business content and procedure explanations concerning the pharmaceutical industry, were carried out by Japan PMDA officials in the first six months of 2014.
      PubDate: Thu, 24 Jul 2014 00:00:11 -040
       
  • Torii Sets Up New Compliance Dept To Improve Clinical Research
    • Abstract: Torii in Japan is to establish a new medical compliance department to strengthen its investigation and management capabilities regarding clinical research, research funding and the utilization of research results.
      PubDate: Wed, 23 Jul 2014 23:55:03 -040
       
  • Survey: Third Of Doctors Save Raw Data For Over 10 Years
    • Abstract: Just over one third of Japanese doctors say they save raw data from clinical research for over 10 years, according to a recent survey.
      PubDate: Wed, 23 Jul 2014 23:50:01 -040
       
  • India Price Cuts May Cause Broad Fallout, Industry Warns
    • Abstract: With the government showing no signs of relenting on its order to cut the prices of dozens of drug brands, the Indian pharma industry has warned of a number of adverse implications that may affect product availability, scar government reputation and leave smaller companies gasping for survival.
      PubDate: Wed, 23 Jul 2014 22:30:00 -040
       
  • Asia On The Move: BMS Names New China Head, Hospira Appoints Japan CEO
    • Abstract: Following J&J, Eli Lilly and other Big Pharma firms, BMS installs new leadership in China, and Wuxi board director and audit committee chairwoman resigns. Meanwhile, Hospira hires Mundipharma executive to head its operation in Japan, and personnel changes take place in Bayer Yakuhin and China Resources Pharma Group.
      PubDate: Wed, 23 Jul 2014 22:20:08 -040
       
  • Emerging Markets Earnings Roundup: Novartis (Part 3)
    • Abstract: Novartis had a busy second quarter with Diovan in the news and a major deal with GSK that portends an evolving focus in emerging markets.
      PubDate: Wed, 23 Jul 2014 22:20:03 -040
       
  • NEC Talking With China Partner To Market Bloodless Sugar Monitor
    • Abstract: Japan's NEC is in the process of forming a partnership with a China partner to market within the year a bloodless device for measuring blood sugar levels in diabetics.
      PubDate: Wed, 23 Jul 2014 18:30:10 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014